Business
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
About this update from Ge Healthcare Technologies Inc.
[{"type":"text","content":"Management to Host Conference Call and Webcast today at 8:30am ET to Discuss Results and Provide Business Update","length":112,"tagName":"p"},{"type":"text","content":"OMER, Israel, March 30, 2026 /PRNewswire/ – Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced financial results for the full year ended December 31, 2025.","length":217,"tagName":"p"},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"image","alt":"Pulsenmore Logo","displaySize":"","headline":null,"caption":"Pulsenmore Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":90,"url":"https://media.zenfs.com/en/prnewswire.com/57a53c102043ee6971ac34f2ca0f3caa"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/4h6fzPsh6_ENgoSUqqhM3A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1OQ--/https://media.zenfs.com/en/prnewswire.com/57a53c102043ee6971ac34f2ca0f3caa","width":400,"height":90}}},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"text","content":"Full-Year 2025 Financial Highlights","length":35,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Full year revenue of $12.5 million, representing a 374% increase compared to 2024, including a one-time revenue contribution of $9.6 million related to the GE settlement discussed below.","length":186,"tagName":"p"}]},{"val":[{"type":"text","content":"Net loss improved significantly to $5 million, compared to $10 million in 2024.","length":79,"tagName":"p"}]},{"val":[{"type":"text","content":"$21.7 million in total liquid assets (including $7 million in cash and cash equivalents) as of December 31, 2025.","length":113,"tagName":"p"}]},{"val":[{"type":"text","content":"Recognized approximately $9.6 million in one-time revenue in connection with a settlement agreement with GE Precision Healthcare LLC (GEHC), which resolved all outstanding disputes between the parties and concluded all related proceedings. Approximately $2.2 million was recognized as revenue from the cancellation of orders placed by GEHC for 15,000 units pursuant to the Settlement Agreement and the termination of the Component Agreement.","length":441,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":819,"olType":false},{"type":"text","content":"Operational Highlights","length":22,"tagNa...